Gene Symbol | Pearson Correlation Coefficient |
---|---|
SYNPO2 | 0.759 |
KLHL38 | 0.704 |
GNPNAT1 | 0.69 |
MREG | 0.689 |
ARNTL2 | 0.671 |
PLCXD2 | 0.661 |
ARHGEF28 | 0.659 |
FILIP1 | 0.655 |
SLIT3 | 0.654 |
GPR63 | 0.654 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
S100A1 | -0.497 |
TLCD1 | -0.475 |
RLBP1 | -0.475 |
PIPOX | -0.459 |
ENDOU | -0.455 |
GPR143 | -0.455 |
STON2 | -0.452 |
RBP1 | -0.44 |
CYP11A1 | -0.437 |
ABHD1 | -0.426 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of FGF10 mRNA | 19933214 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] | 15618436 |
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane affects the expression of FGF10 mRNA" | 18648102 |
C496492 | abrine | abrine results in increased expression of FGF10 mRNA | 22595364 |
D000171 | Acrolein | Acrolein results in decreased expression of FGF10 mRNA | 18515264 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of FGF10 mRNA | 16483693 |
D003913 | Dextroamphetamine | Dextroamphetamine results in increased expression of FGF10 mRNA | 12205029 |
D003913 | Dextroamphetamine | SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of FGF10 mRNA] | 12205029 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of FGF10 mRNA | 24449571 |
D001149 | Arsenates | [Atrazine co-treated with Arsenates] results in increased expression of FGF10 mRNA | 18585445 |
D001151 | Arsenic | Arsenic affects the methylation of FGF10 gene | 25304211 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of FGF10 mRNA | 26705709 |
D001194 | Asbestos | Asbestos results in decreased expression of FGF10 mRNA | 22076105 |
D001194 | Asbestos | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] | 15618436 |
D001194 | Asbestos | FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein] | 15618436 |
D001194 | Asbestos | U 0126 inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] | 15618436 |
D001280 | Atrazine | [Atrazine co-treated with Arsenates] results in increased expression of FGF10 mRNA | 18585445 |
D004958 | Estradiol | Estradiol results in decreased expression of FGF10 mRNA | 15680359 |
D004958 | Estradiol | Estradiol results in decreased expression of FGF10 protein | 15680359 |
C006780 | bisphenol A | bisphenol A results in increased expression of FGF10 mRNA | 25594700 |
C006780 | bisphenol A | bisphenol A results in decreased expression of FGF10 mRNA | 25181051 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FGF10 mRNA | 20147733 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of FGF10 mRNA | 16644059 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of FGF10 mRNA | 17805973 |
C084597 | chlorcyclizine | chlorcyclizine results in increased expression of FGF10 mRNA | 21058326 |
D002713 | Chlorine | Chlorine results in decreased expression of FGF10 mRNA | 18636392 |
D002713 | Chlorine | [Ozone co-treated with Chlorine] affects the expression of FGF10 mRNA | 18636392 |
D002809 | Chondroitin Sulfates | Chondroitin Sulfates analog binds to FGF10 protein | 12221095 |
D002809 | Chondroitin Sulfates | [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein | 15385557 |
D002809 | Chondroitin Sulfates | [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein | 14699094 |
D005576 | Colforsin | Colforsin inhibits the reaction [FGF10 protein results in increased phosphorylation of MAPK1 protein] | 12533312|1497593 |
D005576 | Colforsin | Colforsin inhibits the reaction [FGF10 protein results in increased phosphorylation of MAPK3 protein] | 12533312|1497593 |
C009160 | cyclonite | cyclonite results in decreased expression of FGF10 mRNA | 25559034 |
D003871 | Dermatan Sulfate | [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein | 15385557 |
D003871 | Dermatan Sulfate | [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein | 14699094 |
D003907 | Dexamethasone | Dexamethasone results in decreased expression of FGF10 mRNA | 28453788 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of FGF10 mRNA | 22733784 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of FGF10 mRNA | 19464577|2521318 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of FGF10 protein | 26514922|2891949 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of FGF10 mRNA | 15829613 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of FGF10 mRNA | 25016146 |
C058705 | diethyl malate | diethyl malate affects the expression of FGF10 mRNA | 24814887 |
D004391 | Dust | Dust results in increased secretion of FGF10 protein | 29319804 |
C010452 | estradiol-17 beta-benzoate | estradiol-17 beta-benzoate affects the expression of FGF10 mRNA | 15059950 |
D005419 | Flavonoids | Flavonoids results in increased expression of FGF10 mRNA | 18035473 |
C096856 | FTI 277 | FTI 277 inhibits the reaction [FGF10 protein results in increased expression of and results in increased activity of ATP1A1 protein] | 12804770 |
D019812 | Heparan Sulfate Proteoglycans | Heparan Sulfate Proteoglycans affects the activity of FGF10 protein | 16221725 |
D006493 | Heparin | Heparin promotes the reaction [FGF10 protein binds to FGFR2 protein] | 15632068 |
D006497 | Heparitin Sulfate | Heparitin Sulfate affects the activity of FGF10 protein | 12781692|1281888 |
D006497 | Heparitin Sulfate | Heparitin Sulfate analog binds to FGF10 protein | 14707131 |
D017313 | Fenretinide | Fenretinide results in decreased expression of FGF10 mRNA | 28973697 |
D007213 | Indomethacin | FGF10 protein results in decreased susceptibility to Indomethacin | 11052999 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in decreased expression of FGF10 mRNA" | 19524256 |
D008748 | Methylcholanthrene | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGF10 mRNA | 23519560 |
D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased expression of FGF10 mRNA | 15120970 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of FGF10 mRNA" | 22076105 |
C007350 | nitrofen | nitrofen results in decreased expression of FGF10 mRNA | 11404268 |
C007350 | nitrofen | nitrofen results in decreased expression of FGF10 mRNA | 12861530 |
D016627 | Oxidopamine | Oxidopamine results in increased expression of FGF10 mRNA | 15303306 |
D010126 | Ozone | [Ozone co-treated with Chlorine] affects the expression of FGF10 mRNA | 18636392 |
C029217 | phenyl-N-tert-butylnitrone | phenyl-N-tert-butylnitrone inhibits the reaction [Thalidomide results in decreased expression of FGF10 mRNA] | 12242718 |
D010936 | Plant Extracts | Plant Extracts results in decreased expression of FGF10 mRNA | 23557933 |
D011374 | Progesterone | Progesterone results in increased expression of FGF10 mRNA | 18753603 |
D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of FGF10 mRNA | 24780913 |
C513428 | pyrachlostrobin | pyrachlostrobin results in decreased expression of FGF10 mRNA | 27029645 |
C059514 | resveratrol | resveratrol results in decreased expression of FGF10 mRNA | 23525482|2533817 |
C032706 | sodium chlorate | sodium chlorate affects the activity of FGF10 protein | 12818887 |
C105686 | SU 5402 | SU 5402 results in increased expression of FGF10 mRNA | 12421715 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FGF10 mRNA | 19933214 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased susceptibility to FGF10 protein | 19805408 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of FGF10 mRNA | 26139165 |
D013755 | Tetradecanoylphorbol Acetate | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGF10 mRNA | 23519560 |
D013792 | Thalidomide | phenyl-N-tert-butylnitrone inhibits the reaction [Thalidomide results in decreased expression of FGF10 mRNA] | 12242718 |
D013792 | Thalidomide | Thalidomide results in decreased expression of FGF10 mRNA | 12242718|1471333 |
D014118 | Toxins, Biological | "Toxins, Biological affects the expression of FGF10 mRNA" | 19682533 |
D014212 | Tretinoin | Tretinoin results in increased expression of FGF10 mRNA | 21934132 |
D014212 | Tretinoin | Tretinoin affects the expression of FGF10 | 10862743 |
D014212 | Tretinoin | Tretinoin results in increased expression of FGF10 mRNA | 15328022 |
D014212 | Tretinoin | Tretinoin results in increased expression of FGF10 mRNA | 15328022 |
C012589 | trichostatin A | trichostatin A results in increased expression of FGF10 mRNA | 23463510 |
C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of FGF10 mRNA | 19042947 |
C113580 | U 0126 | U 0126 inhibits the reaction [FGF10 protein results in increased expression of and results in increased activity of ATP1A1 protein] | 12804770 |
C113580 | U 0126 | U 0126 inhibits the reaction [FGF10 protein results in increased phosphorylation of MAPK1 protein] | 12574212 |
C113580 | U 0126 | U 0126 inhibits the reaction [FGF10 protein results in increased phosphorylation of MAPK3 protein] | 12574212 |
C113580 | U 0126 | U 0126 inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] | 15618436 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of FGF10 gene | 25560391 |
C025643 | vinclozolin | vinclozolin results in decreased expression of FGF10 mRNA | 18629315 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004713 | protein tyrosine kinase activity | - | TAS | - |
GO:0005088 | Ras guanyl-nucleotide exchange factor activity | - | TAS | - |
GO:0005104 | fibroblast growth factor receptor binding | - | IDA | 11923311 |
GO:0005111 | type 2 fibroblast growth factor receptor binding | - | IPI | 19224135 |
GO:0005515 | protein binding | - | IPI | 12591959 25241761 |
GO:0008083 | growth factor activity | - | IDA | 11923311 15690149 |
GO:0008201 | heparin binding | - | IDA | 11923311 |
GO:0016303 | 1-phosphatidylinositol-3-kinase activity | - | TAS | - |
GO:0042056 | chemoattractant activity | - | IDA | 9740653 17449030 |
GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity | - | TAS | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000132 | establishment of mitotic spindle orientation | - | IEA | - |
GO:0000165 | MAPK cascade | - | TAS | - |
GO:0000187 | activation of MAPK activity | - | IDA | 14975937 |
GO:0001525 | angiogenesis | - | IEA | - |
GO:0001656 | metanephros development | - | IEP | 18437684 |
GO:0001759 | organ induction | - | IEA | - |
GO:0001823 | mesonephros development | - | IEP | 18437684 |
GO:0001974 | blood vessel remodeling | - | IEA | - |
GO:0003338 | metanephros morphogenesis | - | IEA | - |
GO:0007368 | determination of left/right symmetry | - | IEA | - |
GO:0007431 | salivary gland development | - | IMP | 17213838 |
GO:0008285 | negative regulation of cell proliferation | - | IEA | - |
GO:0008543 | fibroblast growth factor receptor signaling pathway | - | TAS | - |
GO:0008589 | regulation of smoothened signaling pathway | - | IEA | - |
GO:0009880 | embryonic pattern specification | - | IEA | - |
GO:0010469 | regulation of signaling receptor activity | - | IEA | - |
GO:0010631 | epithelial cell migration | - | IEA | - |
GO:0010634 | positive regulation of epithelial cell migration | - | IDA | 17500053 |
GO:0010838 | positive regulation of keratinocyte proliferation | - | IDA | 17449030 |
GO:0018108 | peptidyl-tyrosine phosphorylation | - | IEA | - |
GO:0021983 | pituitary gland development | - | IEA | - |
GO:0030538 | embryonic genitalia morphogenesis | - | IEA | - |
GO:0030878 | thyroid gland development | - | IEA | - |
GO:0030916 | otic vesicle formation | - | IEA | - |
GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | - | IEA | - |
GO:0031016 | pancreas development | - | IEA | - |
GO:0031069 | hair follicle morphogenesis | - | IEA | - |
GO:0031076 | embryonic camera-type eye development | - | IEA | - |
GO:0031532 | actin cytoskeleton reorganization | - | IDA | 17449030 |
GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle | - | IDA | 17188682 |
GO:0032355 | response to estradiol | - | IEA | - |
GO:0032496 | response to lipopolysaccharide | - | IEA | - |
GO:0032781 | positive regulation of ATPase activity | - | IDA | 12804770 |
GO:0032808 | lacrimal gland development | - | IMP | 17213838 |
GO:0032925 | regulation of activin receptor signaling pathway | - | IEA | - |
GO:0034394 | protein localization to cell surface | - | IDA | 17449030 |
GO:0035019 | somatic stem cell population maintenance | - | IEA | - |
GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process | - | IEA | - |
GO:0042060 | wound healing | - | IDA | 11896977 19152659 |
GO:0042246 | tissue regeneration | - | IEA | - |
GO:0042475 | odontogenesis of dentin-containing tooth | - | IEA | - |
GO:0042693 | muscle cell fate commitment | - | IEA | - |
GO:0043410 | positive regulation of MAPK cascade | - | IDA | 12804770 |
GO:0043616 | keratinocyte proliferation | - | IEA | - |
GO:0045596 | negative regulation of cell differentiation | - | IEA | - |
GO:0045739 | positive regulation of DNA repair | - | IDA | 14975937 |
GO:0045740 | positive regulation of DNA replication | - | IMP | 17471512 |
GO:0045747 | positive regulation of Notch signaling pathway | - | IEA | - |
GO:0045893 | positive regulation of transcription, DNA-templated | - | IDA | 17500053 |
GO:0045931 | positive regulation of mitotic cell cycle | - | IEA | - |
GO:0045944 | positive regulation of transcription by RNA polymerase II | - | IEA | - |
GO:0046579 | positive regulation of Ras protein signal transduction | - | IDA | 12804770 |
GO:0046854 | phosphatidylinositol phosphorylation | - | IEA | - |
GO:0046877 | regulation of saliva secretion | - | IMP | 19102732 |
GO:0048146 | positive regulation of fibroblast proliferation | - | IEA | - |
GO:0048536 | spleen development | - | IEA | - |
GO:0048538 | thymus development | - | IDA | 17969154 |
GO:0048557 | embryonic digestive tract morphogenesis | - | IEA | - |
GO:0048754 | branching morphogenesis of an epithelial tube | - | IDA | 17959718 |
GO:0048807 | female genitalia morphogenesis | - | IEA | - |
GO:0048808 | male genitalia morphogenesis | - | IEA | - |
GO:0050671 | positive regulation of lymphocyte proliferation | - | IDA | 19152659 |
GO:0050673 | epithelial cell proliferation | - | IDA | 19224135 |
GO:0050674 | urothelial cell proliferation | - | IDA | 11923311 |
GO:0050677 | positive regulation of urothelial cell proliferation | - | IDA | 11923311 |
GO:0050679 | positive regulation of epithelial cell proliferation | - | IDA | 15690149 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | - | IDA | 17449030 |
GO:0050872 | white fat cell differentiation | - | IEA | - |
GO:0050918 | positive chemotaxis | - | IDA | 9740653 17449030 |
GO:0050930 | induction of positive chemotaxis | - | IEA | - |
GO:0051145 | smooth muscle cell differentiation | - | IEA | - |
GO:0051549 | positive regulation of keratinocyte migration | - | IDA | 17449030 19152659 |
GO:0051897 | positive regulation of protein kinase B signaling | - | TAS | - |
GO:0060019 | radial glial cell differentiation | - | ISS | - |
GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | - | NAS | 19152659 |
GO:0060174 | limb bud formation | - | IEA | - |
GO:0060428 | lung epithelium development | - | IDA | 9740653 |
GO:0060430 | lung saccule development | - | IMP | 17071719 |
GO:0060436 | bronchiole morphogenesis | - | IEA | - |
GO:0060447 | bud outgrowth involved in lung branching | - | IDA | 9740653 |
GO:0060449 | bud elongation involved in lung branching | - | IEA | - |
GO:0060496 | mesenchymal-epithelial cell signaling involved in lung development | - | IEA | - |
GO:0060510 | type II pneumocyte differentiation | - | IEA | - |
GO:0060513 | prostatic bud formation | - | IEA | - |
GO:0060595 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification | - | IDA | 11923311 |
GO:0060615 | mammary gland bud formation | - | IEA | - |
GO:0060661 | submandibular salivary gland formation | - | IEA | - |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | - | IEA | - |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | - | IEA | - |
GO:0060667 | branch elongation involved in salivary gland morphogenesis | - | IEA | - |
GO:0060879 | semicircular canal fusion | - | IEA | - |
GO:0060915 | mesenchymal cell differentiation involved in lung development | - | IEA | - |
GO:0061033 | secretion by lung epithelial cell involved in lung growth | - | IDA | 10541313 |
GO:0061115 | lung proximal/distal axis specification | - | IEA | - |
GO:0070075 | tear secretion | - | IMP | 19102732 |
GO:0070352 | positive regulation of white fat cell proliferation | - | IEA | - |
GO:0070371 | ERK1 and ERK2 cascade | - | IDA | 17959718 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | - | IDA | 14975937 |
GO:0070384 | Harderian gland development | - | IEA | - |
GO:0071157 | negative regulation of cell cycle arrest | - | IDA | 17188682 |
GO:0071338 | positive regulation of hair follicle cell proliferation | - | IDA | 16086254 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | - | IEA | - |
GO:2001240 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005576 | extracellular region | - | TAS | - |
GO:0005615 | extracellular space | - | IDA | 16597614 |
GO:0005634 | nucleus | - | IDA | 11923311 16597614 17471512 |
GO:0005886 | plasma membrane | - | IDA | 16597614 |
GO:0009986 | cell surface | - | IDA | 16597614 |
GO:0009986 | cell surface | - | NAS | 11923311 |
GO:0031012 | extracellular matrix | colocalizes_with | IDA | 17959718 |
KEGG ID | KEGG Term |
---|---|
hsa04010 | MAPK signaling pathway |
hsa04810 | Regulation of actin cytoskeleton |
hsa05200 | Pathways in cancer |
hsa05218 | Melanoma |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109704 | PI3K Cascade | TAS |
R-HSA-112399 | IRS-mediated signalling | TAS |
R-HSA-1226099 | Signaling by FGFR in disease | TAS |
R-HSA-1257604 | PIP3 activates AKT signaling | TAS |
R-HSA-1266738 | Developmental Biology | IEA |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-1643685 | Disease | TAS |
R-HSA-1839126 | FGFR2 mutant receptor activation | TAS |
R-HSA-186712 | Regulation of beta-cell development | IEA |
R-HSA-190236 | Signaling by FGFR | TAS |
R-HSA-190241 | FGFR2 ligand binding and activation | TAS |
R-HSA-190242 | FGFR1 ligand binding and activation | TAS |
R-HSA-190370 | FGFR1b ligand binding and activation | TAS |
R-HSA-190377 | FGFR2b ligand binding and activation | TAS |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | TAS |
R-HSA-2033519 | Activated point mutants of FGFR2 | TAS |
R-HSA-210747 | Regulation of gene expression in early pancreatic precursor cells | IEA |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | TAS |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | TAS |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | TAS |
R-HSA-2428924 | IGF1R signaling cascade | TAS |
R-HSA-2428928 | IRS-related events triggered by IGF1R | TAS |
R-HSA-5654219 | Phospholipase C-mediated cascade: FGFR1 | TAS |
R-HSA-5654221 | Phospholipase C-mediated cascade; FGFR2 | TAS |
R-HSA-5654687 | Downstream signaling of activated FGFR1 | TAS |
R-HSA-5654688 | SHC-mediated cascade:FGFR1 | TAS |
R-HSA-5654689 | PI-3K cascade:FGFR1 | TAS |
R-HSA-5654693 | FRS-mediated FGFR1 signaling | TAS |
R-HSA-5654695 | PI-3K cascade:FGFR2 | TAS |
R-HSA-5654696 | Downstream signaling of activated FGFR2 | TAS |
R-HSA-5654699 | SHC-mediated cascade:FGFR2 | TAS |
R-HSA-5654700 | FRS-mediated FGFR2 signaling | TAS |
R-HSA-5654726 | Negative regulation of FGFR1 signaling | TAS |
R-HSA-5654727 | Negative regulation of FGFR2 signaling | TAS |
R-HSA-5654736 | Signaling by FGFR1 | TAS |
R-HSA-5654738 | Signaling by FGFR2 | TAS |
R-HSA-5655253 | Signaling by FGFR2 in disease | TAS |
R-HSA-5658623 | FGFRL1 modulation of FGFR1 signaling | TAS |
R-HSA-5663202 | Diseases of signal transduction | TAS |
R-HSA-5673001 | RAF/MAP kinase cascade | TAS |
R-HSA-5683057 | MAPK family signaling cascades | TAS |
R-HSA-5684996 | MAPK1/MAPK3 signaling | TAS |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | TAS |
R-HSA-74751 | Insulin receptor signalling cascade | TAS |
R-HSA-74752 | Signaling by Insulin receptor | TAS |
R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
22074045 | The FGF and FGFR Gene Family and Risk of Cleft Lip With or Without Cleft Palate. (2013 Jan) | Wang H | Cleft Palate Craniofac J |
29339516 | Human airway branch variation and chronic obstructive pulmonary disease. (2018 Jan 30) | Smith BM | Proc Natl Acad Sci U S A |
25058584 | The impact of maternal cigarette smoke exposure in a rodent model on renal development in the offspring. (2014) | Al-Odat I | PLoS One |